Oncolytic adenovirus-expressed RNA interference of O6‑methylguanine DNA methyltransferase activity may enhance the antitumor effects of temozolomide

O’Reilly SM, Newlands ES, Glaser MG, et al: Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer. 29A:940–942. 1993.

Bleehen NM, Newlands ES, Lee SM, et al: Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol. 13:910–913. 1995.

Plummer ER, Middleton MR, Jones C, et al: Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes O⁶-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. Clin Cancer Res. 11:3402–3409. 2005.

Fan CH, Liu WL, Cao H, et al: O⁶-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas. Cell Death Dis. 4:e8762013.

Jiang G, Xin Y, Zheng JN and Liu YQ: Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach. Int J Cancer. 129:263–274. 2011.

Bischoff JR, Kirn DH, Williams A, et al: An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 274:373–376. 1996.

Heise C, Hermiston T, Johnson L, et al: An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat Med. 6:1134–1139. 2000.

Rodriguez R, Schuur ER, Lim HY, et al: Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res. 57:2559–2563. 1997.

Garber K: China approves world’s first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst. 98:298–300. 2006.

Chu L, Gu J, Sun L, et al: Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil. Gene Ther. 15:484–494. 2008.

Jiang G, Li LT, Xin Y, et al: Strategies to improve the killing of tumors using temozolomide: targeting the DNA repair protein MGMT. Curr Med Chem. 19:3886–3892

Kuo CC, Liu JF and Chang JY: DNA repair enzyme, O⁶-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors. J Pharmacol Exp Ther. 316:946–954. 2006.

Kato T, Natsume A, Toda H, et al: Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. Gene Ther. 17:1363–1371. 2010.

Zheng JN, Pei DS, Mao LJ, et al: Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA. Cancer Gene Ther. 16:20–32. 2009.

Zheng JN, Pei DS, Sun FH, et al: Inhibition of renal cancer cell growth by oncolytic adenovirus armed short hairpin RNA targeting hTERT gene. Cancer Biol Ther. 8:84–91. 2009.